risedronate sodium - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risedronate risedronate sodium 75mg tablets bottle

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; iron oxide red; colloidal anhydrous silica; hyprolose; magnesium stearate; crospovidone; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risedronate risedronate sodium 75mg film coated tablets blister pack

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hyprolose; iron oxide red; colloidal anhydrous silica; magnesium stearate; hypromellose; macrogol 8000; crospovidone; titanium dioxide; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risedronate risedronate sodium (as hemipentahydrate) 35 mg tablet bottle

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 40.5 mg (equivalent: risedronate sodium, qty 35 mg) - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; lactose; magnesium stearate; iron oxide red; crospovidone; hyprolose; colloidal anhydrous silica; iron oxide yellow - - treatment of osteoporosis. - treatment of glucocorticoid-induced osteoporosis. - preservation of bone mineral density in patients on long term corticosteroid therapy.